Steve Jensen Joins The Weinberg Group (now ProPharma Group)

February 3, 2015

The Weinberg Group (now ProPharma Group), the leading FDA consulting firm, is pleased to announce that Steve Jensen has joined us as Senior Vice President, Head of Regulatory Consulting. Steve has over 20 years of industry experience including executive roles at Iroko, Verus and SkyePharma. He has had responsibility for products under development and launch, including managing multiple FDA submissions and meetings.
"Steve is a welcome addition to our team," said Matthew Weinberg, CEO. "His ability to synthesize a deep regulatory background in tandem with scientific expertise is the essence of what we do. His addition will strengthen the best team in the industry. We look forward to the leadership and guidance Steve will provide."
Steve Jensen

Senior Vice President, Head of Regulatory Consulting

+1 706.286.8841 direct

+1 706.371.8206 mobile

TAGS:

October 3, 2018

The Weinberg Group (now ProPharma Group) Adds Experts to Team

WASHINGTON, DC – OCTOBER 3, 2018 – The Weinberg Group (now ProPharma Group), is growing. In addition to people, the company has also expanded its capabilities. Building upon its role as the most...

New ProPharma office building in Overland Park, Kansas City

August 31, 2013

Featured News for ProPharma Group Kansas Office

Due in large part to the continued support from our loyal clients, ProPharma Group has officially outgrown our existing Kansas location and has relocated to a larger office in Overland Park, Kansas!...

December 15, 2020

Mydecine Innovations Group Engages ProPharma Group to Proceed with FDA Filings and Approval for Novel Research and Multiple Phase Clinical Trials

DENVER, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed to the research,...